Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis (Q39057292)

8 September 2017

title

Role of Mast Cells in the Pathogenesis of Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis (English)

1 reference

experimental autoimmune encephalomyelitis

8 September 2017

main subject

0 references

multiple sclerosis

0 references

mast cell

0 references

author name string

Daniel Elieh-Ali-Komi

series ordinal

1 reference

8 September 2017

Yonghao Cao

series ordinal

1 reference

8 September 2017

publication date

26 December 2016

1 reference

Clinical Reviews in Allergy & Immunology

8 September 2017

published in

1 reference

8 September 2017

1 reference

8 September 2017

1 reference

8 September 2017

page(s)

436-445

1 reference

Multiple sclerosis-a quiet revolution

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Masitinib treatment in patients with progressive multiple sclerosis: a randomized pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Role of the innate immune system in the pathogenesis of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Initial immunopathogenesis of multiple sclerosis: innate immune response.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Pathological mechanisms in progressive multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Exacerbated experimental autoimmune encephalomyelitis in mast-cell-deficient Kit W-sh/W-sh mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

The multitasking mast cell: positive and negative roles in the progression of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

The role of immune cells, glia and neurons in white and gray matter pathology in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Bone marrow-derived mast cells accumulate in the central nervous system during inflammation but are dispensable for experimental autoimmune encephalomyelitis pathogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Revisiting the role of mast cells in autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells in the pathogenesis of multiple sclerosis and experimental autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Immunology of Multiple Sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Impact of Exercise on Innate Immunity in Multiple Sclerosis Progression and Symptomatology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

The pathology of multiple sclerosis is the result of focal inflammatory demyelination with axonal damage

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mechanisms underlying mast cell influence on EAE disease course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Stage-specific immune dysregulation in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Gene-microarray analysis of multiple sclerosis lesions yields new targets validated in autoimmune encephalomyelitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Immunopathogenesis and immunotherapy of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mechanisms of neurodegeneration and axonal dysfunction in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells and neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

New insights into the role of mast cells in autoimmunity: Evidence for a common mechanism of action?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells: new targets for multiple sclerosis therapy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

New insights on mast cell activation via the high affinity receptor for IgE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Differential release of mast cell mediators and the pathogenesis of inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

The role of mast cells in demyelination. 1. Myelin proteins are degraded by mast cell proteases and myelin basic protein and P2 can stimulate mast cell degranulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Elevated mast cell tryptase in cerebrospinal fluid of multiple sclerosis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

How do immune cells overcome the blood-brain barrier in multiple sclerosis?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells: an expanding pathophysiological role from allergy to other disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Meningeal mast cells affect early T cell central nervous system infiltration and blood-brain barrier integrity through TNF: a role for neutrophil recruitment?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Microglia and mast cells: two tracks on the road to neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cell activation by myelin through scavenger receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cell IL-4 expression is regulated by Ikaros and influences encephalitogenic Th1 responses in EAE

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast Cells Exert Effects Outside the Central Nervous System to Influence Experimental Allergic Encephalomyelitis Disease Course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Three decades of research on angiogenin: a review and perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cell inflammasome activity in the meninges regulates EAE disease severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cell activation and neutrophil recruitment promotes early and robust inflammation in the meninges in EAE.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

The crucial role of mast cells in blood-brain barrier alterations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Effect of stress on brain inflammation and multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells are essential for early onset and severe disease in a murine model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Kit (W-sh) mice develop earlier and more severe experimental autoimmune encephalomyelitis due to absence of immune suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Cutting edge: mast cells regulate disease severity in a relapsing-remitting model of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast Cells are Important Modifiers of Autoimmune Disease: With so Much Evidence, Why is There Still Controversy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Role of the innate and adaptive immune responses in the course of multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Neuroprotection and repair in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Impact of mast cells on multiple sclerosis: inhibitory effect of natalizumab

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Important role of mast cells in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Multiple sclerosis: a complicated picture of autoimmunity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

The innate immune system in demyelinating disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Natural killer cells and their receptors in multiple sclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Novel therapeutic strategies for multiple sclerosis--a multifaceted adversary

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Immune cell entry to central nervous system--current understanding and prospective therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Exploring the origins of grey matter damage in multiple sclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells in rheumatic disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells infiltrate pancreatic islets in human type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Evidence of a functional role for mast cells in the development of type 1 diabetes mellitus in the BioBreeding rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

The role of mast cells in neuroinflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS12016-016-8595-Y

Mast cells are required for optimal autoreactive T cell responses in a murine model of multiple sclerosis

21 January 2018

1 reference

12 December 2020

Mast cell adhesion induces cytoskeletal modifications and programmed cell death in oligodendrocytes

1 reference

12 December 2020

Immunopathology of multiple sclerosis

1 reference

12 December 2020

Morphological and functional demonstration of rat dura mater mast cell-neuron interactions in vitro and in vivo

1 reference

12 December 2020

Mast cell and autoimmune diseases

1 reference

12 December 2020

Role of mast cell activation in inducing microglial cells to release neurotrophin

1 reference

12 December 2020

Mast cells contribute to autoimmune diabetes by releasing interleukin-6 and failing to acquire a tolerogenic IL-10+ phenotype

1 reference

12 December 2020

Immunomodulatory functions of type I interferons

1 reference

12 December 2020

Mast cell proteases liberate stable encephalitogenic fragments from intact myelin

1 reference

12 December 2020

10.1007/S12016-016-8595-Y

Identifiers

DOI

1 reference

8 September 2017

1 reference